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Muscle is functionally important for locomotion and as a source of meat. Muscle is highly responsive 
to changes in functional demand and overload can lead to hypertrophy, an increase in cell size. 
Hypertrophy can arise through the expression of transcription factors involved in myogenesis. The 
first of the transcription factor genes coding for muscle-specific proteins are the myogenic regulatory 
factors (MRFs), part of the basic Helix-Loop-Helix (bHLH) transcription factors. The subfamily 
consists of MyoD (also known as Myf-3), Myf-5, myogenin (Myf-1) and MRF4 (Myf-6 or Herculin), 
primary and secondary MRFs involved in expression and hypertrophy. The null hypothesis of this 
study is that in vitro treatments do not induce myotube hypertrophy by acting on transcription factor 
expression and binding to DNA. After differentiation is induced, ovine and murine cell cultures are 
treated with Tumour Necrosis Factor (TNF), Insulin, Insulin-like Growth Factor-1 (IGF-1) and 
Adrenaline. Whole cell protein is collected and nuclear protein extracted to carry out western blotting 
and electrophoretic mobility shift assays (EMSA). Results examine the effects of treatments on gene 
and protein expression and the induction of hypertrophy using computer modulated programs. 
